Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of DSP-5336 Following a Single Oral Dose in Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Myeloproliferative Neoplasms
The purpose of this study is to evaluate the absorption, metabolism, and excretion of DSP-5336 following a single oral administration of the study drug in pati…
Advanced Hematologic Malignancies
Sumitomo Pharma America, Inc.NCT07444268
Phase 1
Phase 1 Trial for Patients With Advanced Hematologic Malignancies Undergoing Reduced Intensity Allogeneic HCT With a T-cell Depleted Graft With Infusion of Conventional T-cells and Regulatory T-cells
Reduced intensity conditioning (RIC) has emerged and been increasingly adopted as a modality to allow preparative conditioning pre transplant to be tolerated b…
Allogeneic Hematopoietic Cell Transplantation (HCT)Advanced Hematologic MalignanciesAcute Leukemia+3 more
Stanford UniversityNCT05088356